Lv1
90 积分 2023-07-25 加入
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
2个月前
已完结
Impact of Preoperative MRI on Survival Outcomes in Patients with HER2-positive and Hormone Receptor–negative Breast Cancer
4个月前
已完结
Assessment of Nonmass Lesions Detected with Screening Breast US Based on Mammographic Findings
6个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
9个月前
已完结
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer
9个月前
已完结
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer
10个月前
已完结
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer
10个月前
已完结
Breast Cancers Detected during a Decade of Screening with Digital Breast Tomosynthesis: Comparison with Digital Mammography
10个月前
已完结
Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models
1年前
已关闭
Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics
1年前
已完结
皖公网安备34019202002308
